← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 30, 2016Last known activity
Aug 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06501651CollaboratorPhase 4Aug 1, 2024
- NCT03228043Reponsible party - principal investigatorN/AMar 1, 2018
- NCT03228043Overall official - principal investigatorN/AMar 1, 2018
- NCT03228043Lead sponsorN/AMar 1, 2018
- NCT03416231Study directorPhase 2Nov 30, 2016
Details
- Last known activity
- Aug 1, 2024